valnoctamide
Small moleculeexperimental
Valnoctamide has been used in France as a sedative-hypnotic since 1964. It is a structural isomer of valpromide, a valproic acid prodrug; unlike valpromide, however, valnoctamide is not transformed into its homologous acid, valnoctic acid, in vivo. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00140179)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCC(C)C(CC)C(N)=O- Mol. weight
- 143.23 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaValnoctamide ↗
- ChEMBLCHEMBL1075733 ↗
Also known as
- 2-ethyl-3-methylpentamide
- axiquel
- axiquel
- mcn-x-181
- mcn-x-181
- nirvanil
- valmethamide
- valmethamide
- valnoctamide
- valnoctamide
- valnoctamide
- valnoctamide
- valnoctamide
- valnoctamide
- valnoctamide
- valnoctamide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00140179 | Phase 3 | Sep 1, 2004 | Ben Gurion University, Stanley Medical Research Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ben Gurion University | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Stanley Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1